- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06923722
De-stressing the Brain: Can Eating Grapes During Periods of Mental Stress Protect Brain and Vascular Health in Young Adults
December 3, 2025 updated by: Catarina Rendeiro, University of Birmingham
A Placebo-controlled, Randomized, Double-masked, Cross-over Acute Intervention Study Investigating the Effects of Grape Polyphenols on Cerebral Oxygenation, Cognitive and Vascular Function in the Context of Mental Stress in Young Adults
The main aim of the current study is to investigate whether consuming grapes rich in flavonoids just before mental stress can protect cerebrovascular and peripheral vascular function, mood and cognition, from the negative effects of mental stress in young healthy adults.
A second, exploratory aim, will further address whether quality of habitual diet, microbiome health (composition; metabolites production e.g.
Short-chain fatty acids) and levels of cardiorespiratory fitness play a role on the beneficial effects of grapes during mental stress.
All participants will receive a high-flavonoid grape intervention (60 g freeze-dried grape powder, equivalent to 300 g fresh grapes) and a low-flavonoid grape intervention (60 g powdere isocaloric-matched control).
It is hypothesized that the high-flavonoid grape intervention will improve cortical oxygenation and cognitive function in the context of mental stress, and prevent the stress-induced decline in peripheral endothelial function following stress.
Furthermore, it is hypothesized that individuals with poorer diets, cardiorespiratory fitness and a poorer gut microbiome will benefit more from the grape intervention in the context of mental stress.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Psychological stress is widespread in our societies, and has been extensively shown to have negative consequences for human health.
Specifically, psychological stress induces significant declines in human vascular function, as measured by brachial Flow-mediated Dilatation (FMD).
We have demonstrated that flavonoid interventions can prevent the harmful effects of stress on the vascular system.
Indeed, flavonoid-rich interventions have also been extensively shown to improve peripheral and cerebrovascular function in the absence of stress.
However, the effect of flavonoids on cerebrovascular function and cognition in the context of mental stress is unknown.
In the proposed project, our key objectives are to investigate whether grape intake prior to a mental stress task results in better brain oxygenation and vascular function, which leads to improved cognitive performance and mood in young healthy adults.
These data will establish whether grapes can be effective as a 'stress snack' to optimize cognitive and brain function in the context of psychological stress.
Furthermore, we will explore whether there are certain participant characteristics that mediate the impact of grape flavonoids on cerebrovascular function and cognition in the context of mental stress.
Such as, physical fitness (assessed by a VO2 max test), composition of gut microbiome (assessed by faecal sample), habitual diet (assessed by 3-day food diary and the food frequency questionnaire), and eating behaviour and chronic stress (assessed by the eating behaviour questionnaire and perceived stress scale).
This work will be important to guide future dietary recommendations around stress and might ultimately result in increased intake of flavonoid-rich grapes and other flavonoid-rich fruits/vegetables overall.
Study Type
Interventional
Enrollment (Estimated)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
West Midlands
-
Birmingham, West Midlands, United Kingdom, B15 2TT
- Recruiting
- School of Sport, Exercise & Rehabilitation Sciences
-
Contact:
- Catarina Rendeiro
- Phone Number: +44 7389190669
- Email: c.rendeiro@bham.ac.uk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Males and females
- 18 - 40 years old
Exclusion Criteria:
- Smokers
- Consumes > 21 units of alcohol per week
- History of cardiovascular, respiratory, metabolic, liver or inflammatory diseases
- Suffers from blood-clotting disorders
- Allergies or intolerances to foods
- On a weight reducing dietary regiment
- Currently taking dietary supplements, including fatty acids and vitamins
- On long-term medication or have been on antibiotics in the last 3 months
- Has an infection at present (e.g. cold) or viral infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High-flavonoid grape intervention
60 g freeze-dried grape powder, equivalent to 300 g fresh grapes (Total polyphenols: 437 mg/100g)
|
High-flavonoid grape powder: 60 g, equivalent to 300 g fresh grapes.
Total polyphenols: 437 mg/100g).
|
|
Placebo Comparator: Low-flavonoid grape intervention
60 g powder isocaloric-matched control (Total polyphenols: < 60 mg)
|
60 g powder isocaloric-matched control (Total polyphenols: < 60 mg)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pre-frontal cortical Tissue Oxygenation Index (NIRS) - TOI
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during mental stress) and 1 hour 15 minutes post-intervention (during cognitive tasks, 10 minutes post-stress)
|
Pre-frontal levels of Tissue Oxygenation Index (% TOI) will be assessed by functional Near-Infrared Spectroscopy (fNIRS).
The NIRS device measures changes in chromophore concentrations of oxyhaemoglobin (O2Hb) and deoxyhaemoglobin (HHb), providing depth-resolved measures of total tissue oxygen saturation.
|
Change from pre-intervention baseline to 1 hour post-intervention (during mental stress) and 1 hour 15 minutes post-intervention (during cognitive tasks, 10 minutes post-stress)
|
|
Pre-frontal cortical Tissue Oxygenation Index (NIRS) - O2Hb
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during mental stress) and 1 hour 15 minutes post-intervention (during cognitive tasks, 10 minutes post-stress).
|
Pre-frontal levels of oxygenated (O2Hb) haemoglobin concentration (μmol) will be assessed by functional Near-Infrared Spectroscopy (fNIRS).
|
Change from pre-intervention baseline to 1 hour post-intervention (during mental stress) and 1 hour 15 minutes post-intervention (during cognitive tasks, 10 minutes post-stress).
|
|
Pre-frontal cortical Tissue Oxygenation Index (NIRS) - HHb
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during mental stress) and 1 hour 15 minutes post-intervention (during cognitive tasks, 10 minutes post-stress).
|
Pre-frontal levels of deoxygenated (HHb) haemoglobin concentration (μmol) will be assessed by functional Near-Infrared Spectroscopy (fNIRS).
|
Change from pre-intervention baseline to 1 hour post-intervention (during mental stress) and 1 hour 15 minutes post-intervention (during cognitive tasks, 10 minutes post-stress).
|
|
Pre-frontal cortical Tissue Oxygenation Index (NIRS) - nTHI
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during mental stress) and 1 hour 15 minutes post-intervention (during cognitive tasks, 10 minutes post-stress).
|
Pre-frontal levels of normalised haemoglobin index (relative value of total haemoglobin normalised to the initial value, nTHI) content (a.u.) will be assessed by functional Near-Infrared Spectroscopy (fNIRS).
|
Change from pre-intervention baseline to 1 hour post-intervention (during mental stress) and 1 hour 15 minutes post-intervention (during cognitive tasks, 10 minutes post-stress).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Flow-mediated dilatation (FMD) of the brachial artery
Time Frame: Change from pre-intervention baseline to 2 hours and 2 hours 45 minutes post-intervention (45-90 minutes post-stress).
|
FMD of the brachial artery.
Expressed as % FMD: change in brachial diameter from baseline to peak dilation following 5 minutes of arterial occlusion.
Brachial artery diameter and blood flow will be measured using Doppler ultrasonography (uSmart 3300, Terason).
|
Change from pre-intervention baseline to 2 hours and 2 hours 45 minutes post-intervention (45-90 minutes post-stress).
|
|
Common Carotid Artery (CCA) - Blood flow
Time Frame: Change from pre-intervention baseline to 2 hours and 2 hours 45 minutes post-intervention (45-90 minutes post-stress).
|
Common Carotid Artery (CCA) blood flow velocity (ml min-1) will be measured using Doppler ultrasonography (uSmart 3300, Terason) interfaced with the Quipu analysis software.
CCA blood flow is calculated using CCA blood velocity and diameter across 2 minutes of recording.
|
Change from pre-intervention baseline to 2 hours and 2 hours 45 minutes post-intervention (45-90 minutes post-stress).
|
|
Common Carotid Artery (CCA) - Shear rate
Time Frame: Change from pre-intervention baseline to 2 hours and 2 hours 45 minutes post-intervention (45-90 minutes post-stress).
|
Common Carotid Artery (CCA) shear rate (s-1) will be measured using Doppler ultrasonography (uSmart 3300, Terason) interfaced with the Quipu analysis software.
|
Change from pre-intervention baseline to 2 hours and 2 hours 45 minutes post-intervention (45-90 minutes post-stress).
|
|
Executive Function (MANT) - Accuracy
Time Frame: Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
Executive function accuracy will be measured using the Modified Attention Network Task (MANT) which measures response to cognitive load
|
Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
|
Executive Function (Switch) - Accuracy
Time Frame: Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
Executive function accuracy will be measured using the Switch Task which considers cognitive flexibility.
|
Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
|
Executive Function (MANT) - Reaction time
Time Frame: Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
Executive function reaction time will be measured using Modified Attention Network Task (MANT) which measures response to cognitive load.
|
Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
|
Executive Function (Switch) - Reaction time
Time Frame: Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
Executive function reaction time will be measured using the Switch Task which considers cognitive flexibility.
|
Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
|
Executive Function (MANT) - Inverse Efficiency Score
Time Frame: Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
Executive function inverse efficiency will be measured using the Modified Attention Network Task (MANT), calculated by dividing task reaction time by task accuracy.
|
Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
|
Executive Function (Switch) - Inverse Efficiency Score
Time Frame: Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
Executive function inverse efficiency will be measured using the Switch Task, calculated by dividing task reaction time by task accuracy.
|
Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress).
|
|
Mood (POMS)
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (immediately following stress), 2 hours and 2 hours 45 minutes post-intervention (45-90 minutes post-stress).
|
Mood (total mood disturbance, TMD) will be assessed by the questionnaire Profile-of-Mood-States (POMS).
|
Change from pre-intervention baseline to 1 hour post-intervention (immediately following stress), 2 hours and 2 hours 45 minutes post-intervention (45-90 minutes post-stress).
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Forearm blood flow (FBF)
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
Venous occlusion plethysmography will assess the forearm vasodilatory response (ml/100ml/min) to mental stress.
|
Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
|
Forearm vascular conductance (FVC)
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
Forearm vascular conductance (FVC) will be calculated by dividing FBF by beat-to-beat mean arterial pressure (MAP).
|
Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
|
Cardiovascular activity - Heart rate (HR)
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
Heart rate (HR, bpm) is assessed using an electrocardiogram.
|
Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
|
Cardiovascular activity - R-wave to pulse interval (RPI)
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
R-wave to pulse interval (RPI, ms) is assessed using an electrocardiogram, to provide an indication of sympathetic activity.
|
Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
|
Cardiovascular activity - Heart rate variability (HRV)
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
Heart rate variability (HRV, ms) is assessed using an electrocardiogram, to provide an indication of parasympathetic activity.
|
Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
|
Cardiovascular activity - beat-to-beat systolic blood pressure (SBP)
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
Beat-to-beat systolic blood pressure (SBP) will be measured using a Finometer (mmHg).
|
Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
|
Cardiovascular activity - beat-to-beat diastolic blood pressure (DBP)
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
Beat-to-beat diastolic blood pressure (SBP) will be measured using a Finometer (mmHg).
|
Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
|
Cardiovascular activity - beat-to-beat mean arterial pressure (MAP)
Time Frame: Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
Beat-to-beat mean arterial pressure (MAP) will be measured using a Finometer (mmHg).
|
Change from pre-intervention baseline to 1 hour post-intervention (during 8 minutes rest and 8 minutes of mental stress).
|
|
Brachial Systolic Blood Pressure (SBP)
Time Frame: Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress), 2 hours post-intervention (45 minutes post-stress) and 2 hour 45 minutes post-intervention (90 minutes post-stress).
|
Resting systolic blood pressure (mmHg) will be measured using an automated oscillometric blood pressure monitor, with a cuff attached to the right upper arm, following at least 10 minutes rest.
|
Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress), 2 hours post-intervention (45 minutes post-stress) and 2 hour 45 minutes post-intervention (90 minutes post-stress).
|
|
Brachial Diastolic Blood Pressure (DBP)
Time Frame: Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress), 2 hours post-intervention (45 minutes post-stress) and 2 hour 45 minutes post-intervention (90 minutes post-stress).
|
Resting diastolic blood pressure (mmHg) will be measured using an automated oscillometric blood pressure monitor, with a cuff attached to the right upper arm, following at least 10 minutes rest.
|
Change from pre-intervention baseline to 1 hour 15 minutes post-intervention (10 minutes post-stress), 2 hours post-intervention (45 minutes post-stress) and 2 hour 45 minutes post-intervention (90 minutes post-stress).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2025
Primary Completion (Estimated)
March 31, 2026
Study Completion (Estimated)
March 31, 2026
Study Registration Dates
First Submitted
March 27, 2025
First Submitted That Met QC Criteria
April 10, 2025
First Posted (Actual)
April 11, 2025
Study Record Updates
Last Update Posted (Estimated)
December 4, 2025
Last Update Submitted That Met QC Criteria
December 3, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ERN_17-1755H
- 3155902 (Other Grant/Funding Number: California Table Grape Comission)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
RAGE BioRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on High-flavonoid grape intervention
-
Purdue UniversityWelch's Food CorporationCompletedAppetitive Behavior | Glycemic ResponseUnited States
-
University of MichiganCalifornia Table Grape CommissionRecruitingPost-operative Atrial Fibrillation (POAF)United States
-
Access Business GroupCompletedHyperlipidemiaUnited States
-
Purdue UniversityWelch's Food CorporationCompletedAppetitive Behavior | Glycemic ResponseUnited States
-
University of ParmaAzienda Ospedaliero-Universitaria di ParmaSuspendedDiet ModificationItaly
-
Utah State UniversityCompletedGut Permeability, Gut InflammationUnited States
-
USDA, Western Human Nutrition Research CenterSonomaceuticals LLCCompleted
-
Fundació EurecatUniversity Rovira i VirgiliRecruitingCardiovascular Diseases | Cholesterol Level, High | Circadian Rhythm Sleep Disorder, Shift Work TypeSpain
-
University of PadovaRecruitingUlcerative Colitis in RemissionItaly
-
Halic UniversityNot yet recruiting